INTAS MIDAZOLAM Midazolam (as hydrochloride) 5 mg/5 mL solution for injection ampoules

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

midazolam, Quantity: 5 mg

Commercializzato da:

Accord Healthcare Pty Ltd

INN (Nome Internazionale):

Midazolam

Forma farmaceutica:

Injection, solution

Composizione:

Excipient Ingredients: sodium chloride; hydrochloric acid; water for injections; sodium hydroxide

Via di somministrazione:

Intramuscular, Intravenous

Confezione:

Pack of 1 ampoule, 5 Ampoules and 10 Ampoules

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

? IV as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic;,? IV for induction of anaesthesia, preliminary to administration of other anaesthetic agents. With the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time.,? IV for sedation in intensive care units; intermittent administration or continuous infusion.,? IM for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Dettagli prodotto:

Visual Identification: Clear, colourless to pale yellow, sterile, isotonic, preservative-free solution in clear glass ampoules (type - 1).; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 48 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2014-05-16